Related Experiment Video
Updated: Jun 6, 2026
Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma
Thomas Horn1, Stephan Schulz, Tobias Maurer
1Urologische Klinik und Poliklinik der Technischen Universität München, Ismaningerstraße 22, 81675 Munich, Germany.
Abstract:
Metastatic spermatocytic seminoma is an extremely rare disease. No chemotherapeutic regimen is established and the use of adjuvant radiation therapy after orchiectomy as frequently performed for classical seminoma is unclear. We report the third case of proven spermatocytic seminoma metastatic in the literature and provide a review of the literature. Administering BEP polychemotherapy as in classical seminoma was poorly effective in reducing the retroperitoneal mass in a patient with spermatocytic seminoma. A review of the literature showed that all the three described patients developing metastatic disease did not receive adjuvant radiation therapy after orchiectomy, which might be considered in high-risk cases.
Insights
Metastatic spermatocytic seminoma is rare, with no standard chemotherapy. Adjuvant radiation therapy after orchiectomy may be beneficial for high-risk cases, as chemotherapy showed limited efficacy.
Area of Science:
- Oncology
- Urologic Oncology
Background:
- Metastatic spermatocytic seminoma is an exceptionally rare clinical diagnosis.
- Established chemotherapeutic regimens and the role of adjuvant radiation therapy post-orchiectomy remain unclear for this condition.
Observation:
- This report details the third documented case of metastatic spermatocytic seminoma in medical literature.
- The patient received BEP polychemotherapy, commonly used for classical seminoma, which demonstrated limited effectiveness in reducing the retroperitoneal mass.
Findings:
- A comprehensive literature review indicates that all three reported cases of metastatic spermatocytic seminoma did not receive adjuvant radiation therapy post-orchiectomy.
- Chemotherapy, specifically BEP, showed poor efficacy in managing the retroperitoneal mass in the presented case.
Implications:
- Adjuvant radiation therapy following orchiectomy should be considered for patients with high-risk metastatic spermatocytic seminoma.
- Further research is warranted to establish optimal treatment protocols for this rare malignancy.
